Warning! GuruFocus detected
4 Severe warning signs
with RCE.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Recce Pharmaceuticals Ltd
ISIN : AU000000RCE5
Description
Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.5 | |||||
| Equity-to-Asset | -1.19 | |||||
| Debt-to-Equity | -0.16 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -3.5 | |||||
| 3-Year EPS without NRI Growth Rate | -5.2 | |||||
| 3-Year FCF Growth Rate | -13.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.37 | |||||
| 9-Day RSI | 42.01 | |||||
| 14-Day RSI | 41.99 | |||||
| 3-1 Month Momentum % | -9.57 | |||||
| 6-1 Month Momentum % | -19.81 | |||||
| 12-1 Month Momentum % | -3.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.36 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -139.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -335.23 | |||||
| ROIC % | -1564.74 | |||||
| 3-Year ROIIC % | -715.14 | |||||
| ROC (Joel Greenblatt) % | -1635.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.55 | |||||
| EV-to-EBITDA | -0.55 | |||||
| EV-to-Forward-EBITDA | -0.14 | |||||
| EV-to-Forward-Revenue | 1.5 | |||||
| EV-to-FCF | -0.64 | |||||
| Earnings Yield (Greenblatt) % | -183.39 | |||||
| FCF Yield % | -132.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Recce Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.092 | ||
| Beta | 0.1 | ||
| 3-Year Sharpe Ratio | -0.43 | ||
| 3-Year Sortino Ratio | -0.66 | ||
| Volatility % | 62.87 | ||
| 14-Day RSI | 41.99 | ||
| 14-Day ATR (A$) | 0.0192 | ||
| 20-Day SMA (A$) | 0.3725 | ||
| 12-1 Month Momentum % | -3.41 | ||
| 52-Week Range (A$) | 0.31 - 0.695 | ||
| Shares Outstanding (Mil) | 27.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Recce Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Recce Pharmaceuticals Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Recce Pharmaceuticals Ltd Frequently Asked Questions
What is Recce Pharmaceuticals Ltd(ASX:RCE)'s stock price today?
The current price of ASX:RCE is A$0.36. The 52 week high of ASX:RCE is A$0.70 and 52 week low is A$0.31.
When is next earnings date of Recce Pharmaceuticals Ltd(ASX:RCE)?
The next earnings date of Recce Pharmaceuticals Ltd(ASX:RCE) is .
Does Recce Pharmaceuticals Ltd(ASX:RCE) pay dividends? If so, how much?
Recce Pharmaceuticals Ltd(ASX:RCE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers